The trial was investigating the use of vagus nerve stimulation (VNS) for inflammatory bowel disease (IBD), an autoimmune ...

The pharma will pay $200 million to buy Nimble and a preclinical oral drug that blocks a protein known as IL-23 — the target ...

Hong Kong-based Insilico Medicine said its generative artificial intelligence (AI) platforms helped it design a molecule that ...

The company has a long presence in therapeutics for the disease, with drugs like TNF inhibitor Humira ... “The prevalence of IBD continues to increase, and many people living with ulcerative ...

Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive tract. It includes conditions such as ulcerative ...

ISM5411 is designed to directly regulate the intestinal immune microenvironment so that the drug simultaneously reduces the gut inflammation seen in IBD while also promoting the repair of the ...

Alternative trial designs should be considered for future novel drugs for IBD." Extended Benefit With Tulisokibart Long-term data from two clinical trials showed the investigational monoclonal ...

Veterans with inflammatory bowel disease (IBD) prioritize shared decision-making ... Biosimilar switching programs offer the ...

Orphagen Pharmaceuticals Receives NIH Funding Award to Advance a Novel Drug for Inflammatory Bowel Disease Funding to support preclinical development of Orphagen’s lead IBD candidate, OR-812, a ...

The symptoms of Irritable Bowel Syndrome IBS and Inflammatory Bowel Disease IBD usually overlap however there’s a vast ...

CDAI, IBD quality of life assessment (IBDQ ... If an antibody promotes clearance there will be no measurable drug in a venous blood sample by week 2 post-infusion. Various strategies can be ...